Sees FY23 revenue $1.1B, consensus $1.12B. The company said, "The Company today announced full year stand-alone 2023 guidance with expected net sales of $1.1 billion and non-GAAP diluted earnings per share of $2.30."
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on GMED:
- Globus Medical Reports Fourth Quarter and Full Year 2022 Results
- Globus Medical downgraded to Underperform from Buy at BofA
- Globus Medical downgraded to Equal Weight from Overweight at Wells Fargo
- NuVasive downgraded to Equal Weight from Overweight at Wells Fargo
- Needham downgrades Globus on ‘meaningful’ integration risks
